FDA Requires Invokana Black Box Warning For Increased Risk of Leg/Foot Amputations
The FDA issued a safety alert on May 16, 2017 regarding Invokana (canagliflozin), a medication used along with diet and exercise to lower blood sugar in adults with type 2 diabetes. after the final results from two clinical studies showed an increased risk of leg and foot amputations associated with[...]